Wednesday, November 18, 2015
Print Current Session:
|
|
Wednesday
SESSION 30:
CLI AND THE ANGIOSOME CONCEPT; REOPERATIONS AND REINTERVENTION; OTHER NEW CONCEPTS AND TECHNIQUES
Moderators:Timur P. Sarac, MD / Cynthia K. Shortell, MD
|
|
SESSION 30 SCHEDULE | |
4:39 PM - 4:44 PM | DEBATE: The Angiosome Concept Has Been Proven Helpful With Open Surgical And Endovascular Treatments Of CLI With Gangrenous Or Ulcerated Lesions |
Presenter(s):Richard F. Neville, MD | |
View Slides in PDF | |
4:45 PM - 4:50 PM | DEBATE: The Angiosome Concept Has Not Been Proven Helpful In The Treatment Of CLI With Gangrenous Or Ulcerated Lesions |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
View Slides in PDF | |
4:51 PM - 4:56 PM | Angiosome Targeted Revascularization Is More Important With Endovascular Repair Than Bypass Surgery |
Presenter(s):Maarit Venermo, MD, PhD | |
View Slides in PDF | |
4:57 PM - 5:02 PM | Critique Of The Angiosome Concept: It Is Not Simple: Outcomes Depend More On The Distribution System In The Foot Than Angiosomes |
Presenter(s):Roberto Ferraresi, MD | |
View Slides in PDF | |
5:03 PM - 5:08 PM | Is The Angiosome Concept Worthwhile And How Should It Be Used |
Presenter(s):Peter A. Schneider, MD | |
View Slides in PDF | |
5:09 PM - 5:14 PM | Update On The Angiosome Concept: It’s Not All It’s Cracked Up To Be: What Other Factors Are More Important |
Presenter(s):Hisham Rashid, FRCS, FRCS(Gen) | |
View Slides in PDF | |
5:15 PM - 5:20 PM | The Angiosome Concept Is Not Necessary To Achieve Limb Salvage With Ischemic Gangrenous Foot Lesions |
Presenter(s):Ignacio Escotto, MD | |
View Slides in PDF | |
5:21 PM - 5:26 PM | Angiosomes Of The Foot Have Tremendous Variability As Indicated By Laser-Assisted Indocyanine Green Imaging Using The SPY SYSTEM |
Presenter(s):Werner Lang, MD | |
View Slides in PDF | |
5:27 PM - 5:32 PM | The Importance Of Reoperation Or Reintervention When A Primary Procedure For CLI Fails And The Limb Is Rethreatened: 1, 2, 3, 4 And More Procedures Can Be Worthwhile: A Vascular Surgeon’s View |
Presenter(s):Evan C. Lipsitz, MD | |
View Slides in PDF | |
NEW CONCEPTS AND TECHNIQUES | |
5:33 PM - 5:38 PM | Vorapaxar - A New PAR-1 Receptor Blocker, Improves Cardiovascular And Limb Outcomes In PAD Patients: The FDA Agrees |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Slides in PDF | |
5:39 PM - 5:44 PM | When And How Should Distal Embolic Protection Devices Be Used With Lower Extremity Interventions |
Presenter(s):D. Christopher Metzger, MD | |
View Slides in PDF | |
5:45 PM - 5:55 PM | Panel Discussion End of Program D |
END OF SESSION 30 | |
previous | next |